About Theravance Biopharma

OUR FOCUS IS ON MAKING A DIFFERENCE

Theravance Biopharma, Inc.’s focus is to deliver Medicines that Make a Difference® in people’s lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Its pipeline of internally discovered programs is targeted to address significant unmet patient needs.

Our Strategic Anchors

Focus on Insight and Innovation

Outsource Non-core Processes

Create and Foster an Integrated Environment

Aggressively Manage Uncertainty

Become a Difference Maker

Learn about our culture, values and current opportunities.

Join Our Team